JP Morgan Chase
BDSX icon

JP Morgan Chase’s Biodesix BDSX Stock Holding History

JP Morgan Chase’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-22
Closed -$822 – 7404
2023
Q4 		$822 Buy
22
+21
+2,100% +$659 ﹤0.01% 6860
2023
Q3 		$18 Buy
+1
New +$28 ﹤0.01% 7187
2022
Q2 		– Sell
-914
Closed -$31K – 6458
2022
Q1 		$31K Sell
914
-1,548
-63% -$101K ﹤0.01% 5947
2021
Q4 		$261K Buy
2,462
+159
+7% +$20.8K ﹤0.01% 5202
2021
Q3 		$379K Buy
2,303
+1,767
+330% +$335K ﹤0.01% 4882
2021
Q2 		$141K Buy
536
+123
+30% +$38.7K ﹤0.01% 5408
2021
Q1 		$167K Buy
413
+12
+3% +$5.36K ﹤0.01% 5215
2020
Q4 		$162K Buy
+401
New +$125K ﹤0.01% 4875

Other funds holding BDSX

BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return

JP Morgan Chase's BDSX Position: Q1 2024 in Review

JP Morgan Chase sold out of Biodesix (BDSX) in Q1 2024, closing a stake of 22 shares — an estimated $822 sold.

JP Morgan Chase first reported a position in BDSX in Q4 2020 and held it in 8 quarters. The position peaked at $379K in Q3 2021. 43 funds tracked by Wall St. Rank hold BDSX as of Q1 2024.

  • JP Morgan Chase reported no remaining Biodesix position as of Q1 2024 after selling out during the quarter.
  • JP Morgan Chase sold 22 Biodesix shares in Q1 2024, an estimated $822.
  • JP Morgan Chase first reported a position in Biodesix in Q4 2020 and held it in 8 quarters.
  • JP Morgan Chase's Biodesix position peaked at $379K in Q3 2021.
  • 43 funds tracked by Wall St. Rank held Biodesix as of Q1 2024.

Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.